[Shanghai: Focus on key areas such as marine APIs and marine biopharmaceuticals, and support the development of marine antibody drugs, new marine vaccines and other products] On November 10, the Shanghai Municipal Ocean Bureau issued the "Shanghai Marine Economic Development "Fifteenth Five-Year Plan" Implementation Plan. It is mentioned that relying on the "Zhangjiang R&D + Shanghai Manufacturing" action to promote the innovative development of the marine biopharmaceutical industry. Strengthen the development of deep-sea biological resources and support the use of marine biological resources to carry out cutting-edge technology research on biomedicine and biological products. Focus on key areas such as marine APIs and marine biopharmaceuticals, and support the development of marine antibody drugs, new marine vaccines and other products. Promote the high-value development of marine biological products and marine functional foods. Promote the use of cutting-edge biotechnologies such as synthetic biology and cell therapy in marine drug research and development. Improve the development capabilities of key seawater desalination technologies and complete sets of equipment, promote independent research and development and large-scale production of reverse osmosis membrane components, strengthen the research and development of key core equipment such as high-pressure pumps and energy recovery devices, and promote membrane technology innovation. Explore the demonstration application of comprehensive utilization of seawater, support the use of seawater desalination as an important emergency backup water source, and strengthen the analysis of potential application scenarios of sea (salt) water desalination.